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 Abstract: Background: The prevalence of anti-drug resistance by disease causing microorganisms 
has necessitated the search for alternative sources of drugs for the treatment of the ailments caused 
by these microorganisms. This study examines the biological properties of extracts from the leaves 
of Irvingia gabonensis (bush mango). 
Objective: The objective of this study is to determine the anti-microbial activity of chloroform 
fraction of the leaf extract and compare it with that of clinical reference. 
Method: Antimicrobial activity of the chloroform fraction of the leaf extract of Irvingia gabonen-
sis was evaluated against Staphylococcus aureus, Escherichia coli, Pseudomonas aeruginosa, Shi-
gella dysenteriae, Salmonella typhi, Klebsiella pneumonia, Salmonella paratyphi, Candida albi-
cans and Trichophyton rubrum by using the agar well diffusion method and Mycobacterium tuber-
culosis using agar proportion method on Lowenstein–Jensen medium. Preliminary phytochemical 
screening of the chloroform leaf fraction was done using qualitative standard methods.  
Result: This showed the presence of saponins, flavonoids, tannins, coumarin, phenol and alkaloids. 
Organisms were susceptible to chloroform fraction at different concentrations. The lowest MIC 
value obtained was 0.625mg/mL for S. aureus and S. typhi. While, five out of seven mycobacterial 
strains that were used, were susceptible.  
Conclusion: The antimicrobial activity is a result of the phytochemicals present in leaf. Therefore, 
we conclude that Irvingia gabonensis leaves can be used in the development of new pharmaceuti-
cals research activities such as drug production. 
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1. INTRODUCTION 
In recent times, it has been observed globally that bacte-
rial and fungal infections are of particular concern as a result 
of the increase in resistance to antimicrobial agents such as 
antibiotic drugs [1]. Organisms like Staphylococcus aureus, 
Salmonella typhi, Klebsiella pneumonia, Escherichia coli, 
Pseudomonas aeruginosa, Salmonella paratyphi, Shigella 
dysenteriae, Candida albicans, Trichophyton rubrum and 
Mycobacterium tuberculosis are emerging in wide new 
varieties of strain which are Multidrug Resistant (MDR). Of 
course, this has made most of the drugs available ineffective. 
The resistance of these organisms poses a threat to the treat-
ment of infectious diseases they cause [2]. It is, therefore, 
necessary that steps be taken to reduce the problems caused  
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by the various strains of bacteria and fungi. Presently, for the 
development and discovery of newer drugs, many plant 
products are evaluated on the basis of their traditional uses. 
Hence, plant derived antimicrobial agents have received con-
siderable attention from pharmacognosy because plants pos-
sess antimicrobial and antiviral activities that can combat 
diseases [2, 3]. 
Interestingly, Irvingia gabonensis is an ethno-medicinal 
plant that has been used for traditional therapeutic purposes 
[4, 5]. Various parts of I. gabonensis have found use in the 
treatment of a variety of ailments, for example, in the treat-
ment of diarrhoea, gastrointestinal, liver conditions, yellow 
fever, relieve body pains, sterility, hernia, urethral discharge, 
as an antidote for poisoning and for reduction of breast-
feeding period [5, 6]. It has also been found to fight obesity, 
reduce body fat, lower body cholesterol and control appetite. 
The seed has been known to reduce blood glucose levels in 
subjects with obesity while the bark has been reported to 
have analgesic effects [7, 8]. The seed extract has been re-
ported to have diuretic effect comparable to that produced by 
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acetazolamide and this effect was found to be dose depend-
ent [9]. The leaf and root were documented to have inhibito-
ry properties against microorganisms [10, 11]. 
This study therefore sought to investigate the antimicro-
bial properties of the chloroform fraction of the extract of I. 
gabonensis against human pathogens such as S. aureus, S. 
typhi, E. coli, P. aeruginosa, S. dysenteriae, K. pneumonia, 
S. paratyphi, C. albican, T. rubrum and M. tuberculosis. In-
formation from this research will assist pharmacology in 
pursuit of new bioactive compounds and improvement on 
antimicrobial drugs. 
2. EXPERIMENTAL 
The bush mango tree (Irvingia gabonensis) grows wild in 
the University premises and the required parts were harvested 
as needed. 
2.1. Plant Material and Extraction 
The extraction of Irvingia gabonensis leaves was carried 
out using known standard procedures [12]. Air-dried leaves 
were ground into powder with a mechanical grinder. The 
powder (300 g) was extracted in ethanol (2 L) by cold macera-
tion for three (3) days. These were filtered out and concentrat-
ed with a rotary evaporator as crude ethanol extract. The crude 
extract was fractionated between chloroform and distilled wa-
ter (1:1) with the aid of separating funnel. The organic chloro-
form layer was collected separately, concentrated as chloro-
form fraction and stored at 2 oC until further use. 
2.2. Preliminary Phytochemical Screening 
The chloroform fraction was subjected to preliminary 
qualitative phytochemical screening to identify the presence 
of saponins, tannin, phenol, alkaloids, flavonoids, triterpe-
noids, cardiac glycoside, steroids, anthraquinone, coumarins 
as described in literature [13-15]. 
2.3. Antimicrobial Studies 
2.3.1. Collection and Maintenance of Test Organisms 
The test organisms that were used for this study were all 
clinical isolates collected from the department of medical 
microbiology and parasitology, Sacred Heart Hospital, 
Lantoro, Abeokuta, Ogun State, Nigeria. 
These isolates include; Staphylococcus aureus, Salmonel-
la typhi, Klebsiella pneumonia, Escherichia coli, Pseudomo-
nas aeruginosa, Shigella dysenteriae, Salmonella paratyphi, 
Candida albicans and Trichophyton rubrum. Biochemical 
analysis such as sugar fermentation, citrate utilization, oxi-
dase reaction, Voges Proskauer, methyl red, capsule staining, 
spore staining, motility, Gram staining, germ tube test, as-
similation tests indole test, urease test, hydrogen sulphide 
test, gelatine liquefaction and gram staining reaction was 
carried out on each test organism. These were then kept as 
stock culture on slant in the refrigerator set at 4ºC [16, 17]. 
2.3.2. Turbidity Standard for Inoculums Preparation 
McFarland standard provides research laboratory guid-
ance for the standardization of numeral organisms for sus-
ceptibility testing or procedures requiring a standardization 
of the inoculums. To standardize the inoculums density for a 
susceptibility test using a modified method by BSAC [18].  
2.3.3. Preparation of Inoculums 
Inoculums are prepared according to the manufacturer’s 
instruction for Mueller Hinton broth. This is comparable to 
that of the 0.5 McFarland standard or against a white back-
ground with conflicting dark line. The inoculums gave semi 
confluent growth of colonies after 18 hours’ incubation. 
Denser inoculums result in a reduced zone of inhibition and 
lighter inoculums have opposite effect. The 0.5 McFarland 
standard provides turbidity comparable to 1.5 x 108 CFU/mL 
bacterial suspension [19]. 
2.3.4. Antimicrobial activity by agar well diffusion method 
Agar well diffusion method was adopted for testing anti-
bacterial activities of fractions. Microbial cultures of 0.5 
McFarland turbidity standard was inoculated on Mueller 
Hinton agar plate with diameter 9 cm. Thereafter, the plates 
were incubated at 37 oC for 24 hours for bacteria at 28 oC 
and 72 hours for fungi. Antimicrobial activity was deter-
mined by measuring the zone of inhibition around each well. 
Duplicate test was conducted against each organism [19]. 
2.3.5. Determination of Minimum Inhibitory Concentration 
(MIC) 
MIC is the lowest concentration of extracts that inhibited 
noticeable growth of the test organisms after 24 hours using 
the tube dilution method as described by the Clinical and La-
boratory Standards Institute [19]. 1 mL of different concen-
trates (0.312 mg/mL, 0.625 mg/mL, 2.5 mg/mL, 5 mg/mL and 
10 mg/mL) of chloroform fraction in nutrient broth is placed 
in different test tubes. A drop of the standardized bacteria was 
added in each test tube and was incubated at 37 oC for 24 
hours. Test was carried out in triplicates for accuracy [19]. 
2.3.6. Anti-Mycobacterial Susceptibility Testing 
Agar proportion method using Lowenstein Jensen media 
was employed for the susceptibility test [20, 21]. The clinical 
isolates of Mycobacterium tuberculosis (drug susceptible and 
drug resistant) were tested against chloroform fraction from 
leaves of I. gabonensis, alongside with two reference drugs, 
which are rifampicin and levofloxacin.  
2.3.7. Drug Susceptibility Testing  
Modified Susceptibility testing against Rifampicin, 
Levofloxacin and chloroform fraction of I. gabonensis leaf 
extract were performed on L–J medium, as described by Fu-
jiki [20] and Canetti et al. [22]. 
3. RESULTS AND DISCUSSION  
Several plant extracts have been reported to show activi-
ties against bacteria and fungi because extracts commonly 
possess antimicrobial activities as a result of the activities of 
plant toxicity to microorganisms. This has proven effective 
in the control and management of different organisms. Figs. 
(1, 2, 3 and 4) below show the charts obtained from the anti-
biotic susceptibility and MIC tests carried out on organisms 
with the chloroform fraction of the ethanol extracts of I. 
gabonensis and its efficacy at different concentration of frac-
tions relative to the standards. 
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Fig. (1). Zone of inhibition for chloroform leaf extract of Irvingia gabonensis against bacteria at different concentrations. 
 
Fig. (2). Zone of inhibition of extract against C. albican and T. rubrum. 
 
3.1. Phytochemical Analysis 
The phytochemical analysis of the chloroform fraction 
revealed the presence of alkaloid, tannin, flavonoid, phenol, 
saponin and coumarin. The presence of these families of 
compounds in fraction confirms the results of previous stud-
ies on the extracts of I. gabonensis [11-29]. These phyto-
chemicals confirm the pharmacological properties reported 
previously such as anti-ulcer and anti-diarrhoea [23], anti-
oxidant [5-24], anti-inflammatory [6], anti- cancer [25] and 
anti-microbial activities [11- 29]. 
3.2. Antibacterial and Antifungal Activities 
The in vitro antibacterial activity and MIC of chloroform 
fraction of the leaves of I. gabonensis shows activity against 
S. aureus, S. typhi, K. pneumoniae, E. coli, P. aeruginosa 
and S. paratyphi using agar well diffusion method Fig. (1). 
The result shows the highest antibacterial activity value 
against S. typhi at 2.5 mg/mL (4 mm) and lowest activity 
value for E. coli at 25 mg/mL (16 mm). Antifungal activity 
of the chloroform fraction from the leaf extract of I. 
gabonensis is reported in Fig. (2) against test organisms (C. 
albicans and T. rubrum). The result obtained reveals highest 
antifungal activity value against C. albicans at 2.5 mg/mL (5 
mm) and lowest activity value for C. albicans at 25 mg/mL 
(14 mm). The MIC values obtained in this study are com-
pared favourably with those reported in the literature for 
some of the test organisms [10- 29]. 
Figs (3 and 4) show the MIC charts for both bacteria and 
fungi against the chloroform fraction. The least concentra-
tion of the chloroform fraction that did not permit any visible 
growth of the inoculated test organism was regarded as the 
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minimum inhibitory concentration (MIC). Figure 3 shows 
that the least MIC for S. aureus and S. typhi is 0.625 mg/mL; 
for K. pneumonia and E. coli is 5 mg/mL and for P. 
aeruginosa and S. paratyphi is10 mg/mL. Also, MIC for 
fungi was seen at 10 mg/mL and 2.5 mg/mL for T. rubrum 
and C. albicans respectively as shown on Figure 4. We can 
safely suggest that chloroform fraction of the extract pos-
sesses toxic activity against bacteria and fungi, thereby con-
firming the reported claim by traditional users for the treat-
ment of ailments caused by these organisms. 
Chloroform fraction of leaf with low activity against test 
organism had a high MIC as in the case of S. aureus and S. 
typhi while active fraction gave a low MIC. This supports 
the claim that I. gabonensis contains chemical constituents 
that have antibacterial and antifungal activities against test 
organisms as reported in the literature [5-26]; making the 
plant a good source of antibiotic drugs. 
3.3. Anti-Mycobacterial Activity 
The result of anti-mycobacterial activity of the chloro-
form fraction on seven M. tuberculosis strains is shown in 
Table 1. These strains were performed on standard L-J media 
method, and incubated for 42 days [20-22]. The Table shows 
that DS-MTB-1 to DS-MTB-5 strains and the H37Rv strain 
were all susceptible to the chloroform fraction of the leaf 
extract of I. gabonensis. This is favourable with the standard 
 
Fig. (3). MIC values at different concentration for chloroform leaf extract. 
 
Fig. (4). MIC for extract against at different concentration standard drug, C. albican and T. rubrum. 
Table 1. Anti-mycobacterial activity of chloroform Fraction. 
DS-MTB 1 DS-MTB 2 DS-MTB 3 DS-MTB 4 DS-MTB 5 DR-MTB 1 DR-MTB 2 H37Rv Rifampicin Levoflaxacin 
S S S S S R R S S S - 
Rifampicin 40 mg and Levofloxacin 200 mg was used as control; DS- Drug susceptible Strains; DR-Drug Resistant Strains. 
Bacteria	  MIC	  
10	  mg/	  mL	   5	  mg/mL	   2.5	  mg/mL	   0.625	  mg/mL	   0.313	  mg/mL	  
C.	  albicans	   T.	  rubrum	   Control	  
MIC	  chart	  against	  fungi	  	  
10	  mg/mL	   5	  mg/mL	   2.5	  mg/mL	   0.625	  mg/mL	   0.313	  mg/mL	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drugs (Rifampicin and Levofloxacin) used. The result pro-
vides evidence that the leaves are a potential source of anti-
TB agent, suggesting that the phyto-constituents responsible 
for the activity may be the presence in the chloroform frac-
tion. [30]. Therefore, there is a need to isolate and elucidate 
the phyto-constituent(s) responsible for the anti-myco-
bacterial activity. 
CONCLUSION 
This study therefore observed that the in-vitro antimicro-
bial activity of the chloroform fraction against some selected 
organisms (S. aureus, S. typhi, K. pneumonia, E. coli, P. 
aeruginosa, S. paratyphi C. albicans, T. rubrum and M. tu-
berculosis) at different concentrations justifies the traditional 
claims and applications in disease management. To the best 
of our knowledge, this study reports the in vitro anti-
mycobacterial activity of plant extract for the first time. I. 
gabonensis is used in the treatment remedy for yellow fever, 
diarrhoea, diabetes and wound healing [27]. Hence, with the 
result obtained from this investigations, the chloroform frac-
tion of the methanolic extracts of I. gabonensis leaf was found 
to be active against some organisms, as compared to the 
standard drugs. This justifies the traditional use of the leaf in 
infectious conditions. However, before it is used by human 
beings, isolation of pure compound, toxicological study, and 
pharmacological activity should be carried out to better eval-
uate the potential efficiency of the chloroform fraction from 
ethanol crude extract as the antimicrobial agents. 
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